Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$554M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$435M |
| 3 |
CERN
Cerner Corp
CERN
|
+$282M |
| 4 |
Norfolk Southern
NSC
|
+$238M |
| 5 |
ExxonMobil
XOM
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.35B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$966M |
| 4 |
NVIDIA
NVDA
|
+$768M |
| 5 |
AT&T
T
|
+$594M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.17% |
| 2 | Financials | 6.59% |
| 3 | Healthcare | 6.12% |
| 4 | Industrials | 4.26% |
| 5 | Consumer Discretionary | 3.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
CALL
United Therapeutics
UTHR
$25.7B
| $4.49M | ﹤0.01% |
+25,000
| New | +$4.76M |
|
|
PSPC
3002
DELISTED
Post Holdings Partnering Corporation
PSPC
| $4.49M | ﹤0.01% |
458,598
+17,228
| +4% | +$168K |
|
|
LNW
3003
DELISTED
Light & Wonder
LNW
| $4.48M | ﹤0.01% |
76,320
-137,767
| -64% | -$8.33M |
|
3004
PUT
Arcus Biosciences
RCUS
$3.47B
| $4.48M | ﹤0.01% |
+141,900
| New | +$4.75M |
|
|
SKE
3005
Skeena Resources
SKE
$3.36B
| $4.48M | ﹤0.01% |
401,732
+346,369
| +626% | +$3.9M |
|
|
BLUE
3006
DELISTED
bluebird bio
BLUE
| $4.47M | ﹤0.01% |
46,137
+19,578
| +74% | +$2.58M |
|
|
CBD
3007
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $4.47M | ﹤0.01% |
887,907
+635,402
| +252% | +$2.7M |
|
3008
Tevogen Inc. Common Stock
TVGN
$29.6M
| $4.47M | ﹤0.01% |
+8,958
| New | +$4.45M |
|
3009
Corvus Pharmaceuticals
CRVS
$1.12B
| $4.47M | ﹤0.01% |
2,723,539
-196,520
| -7% | -$360K |
|
3010
The Joint Corp
JYNT
$117M
| $4.46M | ﹤0.01% |
125,870
+30,240
| +32% | +$1.4M |
|
|
DLCA
3011
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
| $4.46M | ﹤0.01% |
454,103
+6,848
| +2% | +$66.9K |
|
3012
Afya
AFYA
$1.3B
| $4.44M | ﹤0.01% |
308,379
+230,066
| +294% | +$3.15M |
|
3013
Truist Financial
TFC
$63.4B
| $4.44M | ﹤0.01% |
78,331
-539,984
| -87% | -$33.4M |
|
3014
Raymond James Financial
RJF
$34.1B
| $4.44M | ﹤0.01% |
40,371
-511,008
| -93% | -$54.1M |
|
3015
Zurn Elkay Water Solutions
ZWS
$8.49B
| $4.43M | ﹤0.01% |
125,284
+106,280
| +559% | +$3.53M |
|
3016
Sixth Street Specialty
TSLX
$1.68B
| $4.43M | ﹤0.01% |
+190,375
| New | +$4.46M |
|
|
TMAC
3017
DELISTED
The Music Acquisition Corporation
TMAC
| $4.43M | ﹤0.01% |
454,617
-12,220
| -3% | -$119K |
|
3018
First Advantage
FA
$3.5B
| $4.43M | ﹤0.01% |
219,461
+130,615
| +147% | +$2.25M |
|
3019
Q2 Holdings
QTWO
$3.89B
| $4.43M | ﹤0.01% |
71,876
+42,807
| +147% | +$2.74M |
|
3020
Enovix
ENVX
$921M
| $4.42M | ﹤0.01% |
353,969
+128,239
| +57% | +$1.8M |
|
|
ANAC
3021
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
| $4.42M | ﹤0.01% |
450,992
+47,445
| +12% | +$462K |
|
|
GMS
3022
DELISTED
GMS Inc
GMS
| $4.41M | ﹤0.01% |
88,661
+4,843
| +6% | +$255K |
|
3023
Forrester Research
FORR
$221M
| $4.39M | ﹤0.01% |
77,890
+17,305
| +29% | +$933K |
|
3024
PUT
Hasbro
HAS
$12.9B
| $4.38M | ﹤0.01% |
53,500
| – | – |
|
3025
Maximus
MMS
$3.27B
| $4.38M | ﹤0.01% |
58,381
-361,308
| -86% | -$27.6M |
|
Similar funds
Millennium Management's Q1 2022 Portfolio in Review
As of Q1 2022, Millennium Management held 8,193 positions worth $189B, down 4.1% from $197B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Millennium Management's Q1 2022 filing shows 1,492 new, 2,451 increased, 2,453 reduced and 1,365 closed positions. Its largest new stake was Mondelez International: 1,780,636 shares worth $112M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.35B.
By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.9% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q1 2022 buy was Mondelez International: 1,780,636 shares worth $112M.
- Millennium Management added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $554M increase.
- Millennium Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.35B.
- Millennium Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $532M.
- Millennium Management's ten largest holdings make up 24% of its $189B portfolio in Q1 2022.
- Millennium Management opened 1,492 new positions and closed 1,365 in Q1 2022.
- Millennium Management's portfolio value fell 4.1% quarter-over-quarter to $189B.
Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.